# Real-world Patient Reported Outcomes Among Patients Treated With Camzyos

> **NCT06551129** · — · RECRUITING · sponsor: **Bristol-Myers Squibb** · enrollment: 118 (estimated)

## Conditions studied

- Obstructive Hypertrophic Cardiomyopathy

## Interventions

- **DRUG:** Mavacamten

## Key facts

- **NCT ID:** NCT06551129
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-10
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-06-30
- **Target enrollment:** 118 (ESTIMATED)
- **Last updated:** 2024-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06551129

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06551129, "Real-world Patient Reported Outcomes Among Patients Treated With Camzyos". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06551129. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*